Alibaba cooperates with WHO to promote AI cancer screening technology globally
On June 1, IT House reported that yesterday (May 31), the United Nations held the AI for Good Global Summit in Geneva, Switzerland. Alibaba and the WHO Digital Health Cooperation Center reached a strategic cooperation to promote the AI cancer screening technology of Damo Hospital globally. Alibaba said that in China, the AI cancer early screening technology of Dharma Hospital has provided services for more than 6 million people, covering the screening of pancreatic cancer, esophageal cancer, intestinal cancer, gastric cancer, liver cancer and other diseases, and has reached strategic cooperation with the Ministry of Health of Antigua and Barbuda internationally. After this signing, the WHO Digital Health International Cooperation Center will provide support from channels, markets, implementation, technology, standards and other aspects. More developing countries and regions with unbalanced medical resources in the world will share this cutting-edge achievement. According to the official introduction of Alibaba, as early as October 2022, the company initially verified the technical feasibility of the combination of AI and flat scan CT. In November last year, Alibaba, together with more than 10 top research institutions in the world, released the pancreatic cancer detection model PANDA, which was the first time to put forward the concept of "plain scan C